Chemika’s Analytical Development Manager, Andrew Jones, and Managing Director, Alan Doughty, attended the BIO International Convention 2025 in Boston in June.
We were proud to be part of the NSW Government’s ‘Investment NSW’ initiative under the NSW Going Global Health to the USA export program, joining over 200 Australian companies. This initiative promoted Australia’s life sciences industry to more than 14,000 attendees and 1,400 exhibiting organizations.
Supporting the Australian clinical trials ecosystem
As part of ‘Team Australia’ we helped promote the nation as an ideal location for clinical trials. Chemika supports clinical trials by providing essential services like:
- Chemical testing of new drug formulations.
- Establishing early stability data to ensure confidence as trials proceed.
- Offering supplementary testing, including organic/inorganic impurity testing, photostability, and in-use stability studies.
Bringing global experience home
Attending the BIO convention in Boston provided a valuable opportunity to witness the vast scope of the international life sciences industry and gain a deeper understanding of global operational models. This experience is not merely informational; it allows us to integrate international best practices, ensuring Chemika continues to provide world-class analytical services and strengthens our partnership with clients operating on a global scale.